 Samuel Gubbels
Concepts (357)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 8 | 2023 | 91 | 3.600 |
Why?
| | Cochlear Implantation | 8 | 2023 | 81 | 3.090 |
Why?
| | Neuroma, Acoustic | 7 | 2022 | 35 | 2.580 |
Why?
| | Hearing Loss | 7 | 2022 | 186 | 2.350 |
Why?
| | Cochlea | 9 | 2023 | 88 | 2.080 |
Why?
| | Hearing | 8 | 2023 | 135 | 1.680 |
Why?
| | Semicircular Canals | 4 | 2021 | 28 | 1.580 |
Why?
| | Speech Perception | 5 | 2022 | 81 | 1.480 |
Why?
| | Otitis Media | 7 | 2022 | 146 | 1.200 |
Why?
| | Radiosurgery | 3 | 2019 | 318 | 1.160 |
Why?
| | Deafness | 5 | 2023 | 79 | 1.160 |
Why?
| | Ear, Inner | 5 | 2020 | 39 | 1.120 |
Why?
| | Nestin | 2 | 2016 | 16 | 1.110 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 20 | 1.010 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.950 |
Why?
| | Gentamicins | 1 | 2023 | 42 | 0.910 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 45 | 0.910 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 9 | 0.830 |
Why?
| | Endoscopy | 3 | 2020 | 272 | 0.810 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 19 | 0.810 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 13 | 0.790 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 65 | 0.760 |
Why?
| | Otolaryngologists | 1 | 2020 | 13 | 0.750 |
Why?
| | Hair Cells, Auditory | 4 | 2021 | 39 | 0.730 |
Why?
| | Paraganglioma | 1 | 2020 | 48 | 0.700 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 29 | 0.690 |
Why?
| | Audiometry, Pure-Tone | 4 | 2018 | 24 | 0.680 |
Why?
| | Tinnitus | 3 | 2018 | 61 | 0.680 |
Why?
| | Vertigo | 3 | 2023 | 35 | 0.670 |
Why?
| | Ear Neoplasms | 1 | 2018 | 4 | 0.670 |
Why?
| | Eustachian Tube | 1 | 2018 | 4 | 0.670 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3174 | 0.660 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 60 | 0.650 |
Why?
| | Meningioma | 1 | 2019 | 82 | 0.650 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 90 | 0.640 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 54 | 0.640 |
Why?
| | Hearing Aids | 2 | 2016 | 68 | 0.610 |
Why?
| | Radiation Injuries | 1 | 2018 | 131 | 0.610 |
Why?
| | Physicians' Offices | 1 | 2016 | 16 | 0.580 |
Why?
| | Surgical Flaps | 2 | 2016 | 118 | 0.570 |
Why?
| | Membrane Proteins | 2 | 2020 | 1055 | 0.560 |
Why?
| | Sex Characteristics | 1 | 2021 | 671 | 0.550 |
Why?
| | Suture Anchors | 1 | 2016 | 34 | 0.550 |
Why?
| | Humans | 59 | 2023 | 118974 | 0.540 |
Why?
| | Skin Transplantation | 1 | 2016 | 58 | 0.540 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 471 | 0.510 |
Why?
| | Device Removal | 1 | 2016 | 127 | 0.510 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 7 | 0.510 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 4 | 0.510 |
Why?
| | Cell Differentiation | 2 | 2021 | 1753 | 0.510 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 66 | 0.500 |
Why?
| | Blood | 1 | 2014 | 100 | 0.490 |
Why?
| | Hyperacusis | 1 | 2014 | 8 | 0.490 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2436 | 0.490 |
Why?
| | Cholesteatoma | 1 | 2014 | 13 | 0.480 |
Why?
| | Temporal Bone | 5 | 2017 | 43 | 0.450 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.440 |
Why?
| | Jugular Veins | 1 | 2013 | 47 | 0.440 |
Why?
| | Polyvinyls | 1 | 2012 | 17 | 0.440 |
Why?
| | Bacteremia | 1 | 2014 | 161 | 0.440 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.440 |
Why?
| | Patient Selection | 1 | 2016 | 676 | 0.440 |
Why?
| | Influenza B virus | 1 | 2012 | 33 | 0.430 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 34 | 0.430 |
Why?
| | Mutation | 2 | 2020 | 3457 | 0.430 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 42 | 0.430 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 15 | 0.430 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 709 | 0.430 |
Why?
| | Influenza A virus | 1 | 2012 | 90 | 0.410 |
Why?
| | Melanoma | 1 | 2018 | 664 | 0.410 |
Why?
| | Denmark | 5 | 2016 | 41 | 0.410 |
Why?
| | Stapes Surgery | 2 | 2023 | 14 | 0.410 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 551 | 0.390 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 140 | 0.390 |
Why?
| | Middle Aged | 19 | 2022 | 27617 | 0.380 |
Why?
| | Artifacts | 2 | 2023 | 125 | 0.380 |
Why?
| | Aging | 2 | 2021 | 1670 | 0.380 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 192 | 0.370 |
Why?
| | Otologic Surgical Procedures | 4 | 2021 | 16 | 0.370 |
Why?
| | Fucosyltransferases | 2 | 2022 | 30 | 0.370 |
Why?
| | Laser Therapy | 2 | 2023 | 104 | 0.370 |
Why?
| | Female | 25 | 2023 | 61565 | 0.360 |
Why?
| | Genetic Therapy | 5 | 2020 | 267 | 0.360 |
Why?
| | Male | 28 | 2022 | 57801 | 0.350 |
Why?
| | Transfection | 2 | 2009 | 888 | 0.350 |
Why?
| | Retrospective Studies | 14 | 2022 | 12978 | 0.340 |
Why?
| | Adult | 20 | 2023 | 31512 | 0.330 |
Why?
| | Bacteria | 1 | 2014 | 757 | 0.320 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 5 | 0.320 |
Why?
| | Encephalocele | 1 | 2007 | 7 | 0.320 |
Why?
| | Intensive Care Units | 1 | 2012 | 635 | 0.320 |
Why?
| | Nasopharynx | 2 | 2022 | 64 | 0.320 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 136 | 0.310 |
Why?
| | Uterus | 1 | 2008 | 194 | 0.300 |
Why?
| | Hearing Tests | 2 | 2020 | 49 | 0.300 |
Why?
| | Cross Infection | 2 | 2022 | 205 | 0.300 |
Why?
| | Neurons | 1 | 2015 | 1345 | 0.290 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 219 | 0.290 |
Why?
| | Animals | 16 | 2023 | 33381 | 0.290 |
Why?
| | Influenza, Human | 1 | 2012 | 554 | 0.280 |
Why?
| | Tracheal Diseases | 1 | 2006 | 16 | 0.280 |
Why?
| | Bioprosthesis | 1 | 2006 | 36 | 0.280 |
Why?
| | Mice | 10 | 2023 | 15520 | 0.270 |
Why?
| | Aged | 13 | 2022 | 19657 | 0.250 |
Why?
| | Trachea | 1 | 2006 | 226 | 0.250 |
Why?
| | Incidence | 5 | 2016 | 2424 | 0.240 |
Why?
| | Airway Obstruction | 1 | 2006 | 168 | 0.240 |
Why?
| | Treatment Outcome | 9 | 2022 | 9342 | 0.240 |
Why?
| | Audiometry | 2 | 2014 | 33 | 0.230 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 16 | 0.230 |
Why?
| | Cadaver | 5 | 2023 | 327 | 0.230 |
Why?
| | Penicillins | 1 | 2023 | 50 | 0.230 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 43 | 0.230 |
Why?
| | Meniere Disease | 1 | 2023 | 30 | 0.220 |
Why?
| | Synapses | 2 | 2021 | 344 | 0.220 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 4 | 0.220 |
Why?
| | Migraine Disorders | 1 | 2023 | 79 | 0.210 |
Why?
| | Haemophilus Infections | 1 | 2022 | 31 | 0.210 |
Why?
| | Aged, 80 and over | 6 | 2016 | 6561 | 0.210 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 153 | 0.200 |
Why?
| | Microsurgery | 2 | 2020 | 64 | 0.200 |
Why?
| | Otolithic Membrane | 1 | 2021 | 3 | 0.200 |
Why?
| | Labyrinthitis | 1 | 2021 | 2 | 0.200 |
Why?
| | Neurons, Efferent | 1 | 2021 | 7 | 0.200 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 531 | 0.200 |
Why?
| | Vestibular Nerve | 1 | 2021 | 16 | 0.200 |
Why?
| | Vestibular Diseases | 1 | 2021 | 22 | 0.200 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 508 | 0.190 |
Why?
| | Scoliosis | 1 | 2023 | 183 | 0.190 |
Why?
| | Plasminogen | 1 | 2020 | 34 | 0.190 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2025 | 0.190 |
Why?
| | Noise | 1 | 2021 | 67 | 0.190 |
Why?
| | Ear, Middle | 4 | 2022 | 92 | 0.180 |
Why?
| | Magnets | 1 | 2019 | 15 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2023 | 268 | 0.180 |
Why?
| | Microbiota | 3 | 2022 | 656 | 0.180 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.170 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 5 | 0.170 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 15 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2020 | 300 | 0.160 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 4908 | 0.160 |
Why?
| | Mucous Membrane | 1 | 2018 | 113 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 93 | 0.160 |
Why?
| | Surgical Equipment | 1 | 2017 | 13 | 0.150 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 16 | 0.150 |
Why?
| | Neurotology | 1 | 2017 | 1 | 0.150 |
Why?
| | Genetic Testing | 1 | 2020 | 389 | 0.150 |
Why?
| | Hospitals | 3 | 2022 | 598 | 0.150 |
Why?
| | Infant | 7 | 2019 | 8293 | 0.150 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 395 | 0.150 |
Why?
| | Dissection | 1 | 2017 | 55 | 0.150 |
Why?
| | Adolescent | 8 | 2023 | 18480 | 0.140 |
Why?
| | Regeneration | 1 | 2018 | 165 | 0.140 |
Why?
| | Patient Positioning | 1 | 2017 | 49 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.140 |
Why?
| | Child, Preschool | 7 | 2019 | 9491 | 0.140 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 7 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 755 | 0.140 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1384 | 0.140 |
Why?
| | Age Factors | 3 | 2012 | 2995 | 0.140 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 97 | 0.140 |
Why?
| | Automation | 1 | 2016 | 77 | 0.140 |
Why?
| | Organogenesis | 1 | 2016 | 54 | 0.140 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 167 | 0.140 |
Why?
| | Scalp | 1 | 2016 | 29 | 0.140 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 49 | 0.140 |
Why?
| | Quality of Life | 3 | 2023 | 2366 | 0.140 |
Why?
| | Child | 9 | 2023 | 19129 | 0.130 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.130 |
Why?
| | Ifosfamide | 1 | 2015 | 31 | 0.130 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 39 | 0.130 |
Why?
| | Durapatite | 2 | 2021 | 33 | 0.130 |
Why?
| | Etoposide | 1 | 2015 | 149 | 0.130 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 108 | 0.130 |
Why?
| | Educational Measurement | 1 | 2017 | 289 | 0.130 |
Why?
| | Audiology | 1 | 2014 | 17 | 0.120 |
Why?
| | Young Adult | 6 | 2019 | 10793 | 0.120 |
Why?
| | Animals, Newborn | 1 | 2016 | 806 | 0.120 |
Why?
| | Pedigree | 3 | 2020 | 485 | 0.120 |
Why?
| | Tamoxifen | 1 | 2015 | 198 | 0.120 |
Why?
| | Luminescent Proteins | 1 | 2015 | 174 | 0.120 |
Why?
| | Methotrexate | 1 | 2015 | 227 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2017 | 2874 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1510 | 0.120 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 3 | 0.120 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 11 | 0.120 |
Why?
| | Genetic Variation | 1 | 2018 | 926 | 0.110 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 55 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2010 | 4596 | 0.110 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.110 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 6 | 0.110 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 12 | 0.110 |
Why?
| | Disease Notification | 1 | 2012 | 15 | 0.110 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 11 | 0.110 |
Why?
| | Meat Products | 1 | 2012 | 25 | 0.110 |
Why?
| | Seasons | 1 | 2014 | 461 | 0.110 |
Why?
| | Food Contamination | 1 | 2012 | 45 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1597 | 0.110 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 387 | 0.110 |
Why?
| | Disease Progression | 1 | 2019 | 2490 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 612 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2013 | 97 | 0.100 |
Why?
| | Phenotype | 1 | 2020 | 3003 | 0.100 |
Why?
| | Vestibule, Labyrinth | 1 | 2012 | 54 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1868 | 0.100 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.100 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.100 |
Why?
| | Foodborne Diseases | 1 | 2012 | 49 | 0.100 |
Why?
| | Sex Factors | 2 | 2014 | 1781 | 0.100 |
Why?
| | Viral Tropism | 1 | 2011 | 24 | 0.100 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 10 | 0.100 |
Why?
| | Age Distribution | 1 | 2012 | 362 | 0.100 |
Why?
| | Sex Distribution | 1 | 2012 | 351 | 0.100 |
Why?
| | Ear Canal | 1 | 2011 | 15 | 0.100 |
Why?
| | Skull Base | 2 | 2021 | 44 | 0.100 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 164 | 0.100 |
Why?
| | Dependovirus | 1 | 2011 | 52 | 0.100 |
Why?
| | Lasers | 2 | 2023 | 124 | 0.100 |
Why?
| | Radiography | 1 | 2014 | 861 | 0.100 |
Why?
| | Ganglion Cysts | 1 | 2011 | 10 | 0.100 |
Why?
| | Ear Diseases | 1 | 2011 | 14 | 0.100 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 6 | 0.100 |
Why?
| | Zygoma | 1 | 2010 | 11 | 0.100 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1795 | 0.100 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 210 | 0.090 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 174 | 0.090 |
Why?
| | Adenoviridae | 1 | 2011 | 191 | 0.090 |
Why?
| | Cost of Illness | 1 | 2012 | 258 | 0.090 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 154 | 0.090 |
Why?
| | Clinical Competence | 1 | 2017 | 951 | 0.090 |
Why?
| | Electroencephalography | 1 | 2012 | 387 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2011 | 302 | 0.090 |
Why?
| | Abscess | 1 | 2010 | 75 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2445 | 0.090 |
Why?
| | Prospective Studies | 3 | 2012 | 6471 | 0.090 |
Why?
| | Maxilla | 1 | 2009 | 29 | 0.090 |
Why?
| | Disease Outbreaks | 1 | 2012 | 322 | 0.090 |
Why?
| | Skull Fractures | 1 | 2009 | 30 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2016 | 2275 | 0.080 |
Why?
| | Population Surveillance | 1 | 2012 | 413 | 0.080 |
Why?
| | Electroporation | 1 | 2009 | 33 | 0.080 |
Why?
| | Comorbidity | 1 | 2014 | 1527 | 0.080 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 13 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 499 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 642 | 0.080 |
Why?
| | Electric Conductivity | 1 | 2008 | 91 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 693 | 0.080 |
Why?
| | Dyneins | 1 | 2008 | 30 | 0.080 |
Why?
| | Cleft Lip | 1 | 2008 | 33 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2008 | 3730 | 0.080 |
Why?
| | Swine | 2 | 2012 | 730 | 0.080 |
Why?
| | Myosins | 1 | 2008 | 130 | 0.080 |
Why?
| | Cleft Palate | 1 | 2008 | 48 | 0.080 |
Why?
| | Chronic Disease | 1 | 2014 | 1636 | 0.080 |
Why?
| | Bone Cements | 1 | 2007 | 39 | 0.080 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 101 | 0.080 |
Why?
| | Craniotomy | 1 | 2007 | 69 | 0.080 |
Why?
| | Internship and Residency | 1 | 2017 | 1001 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1390 | 0.070 |
Why?
| | Neck Dissection | 1 | 2005 | 10 | 0.070 |
Why?
| | Postoperative Care | 1 | 2007 | 237 | 0.070 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 8 | 0.070 |
Why?
| | Biomarkers | 1 | 2016 | 3588 | 0.070 |
Why?
| | Prevalence | 1 | 2012 | 2326 | 0.070 |
Why?
| | Random Allocation | 1 | 2006 | 344 | 0.070 |
Why?
| | Neck | 1 | 2005 | 89 | 0.070 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 83 | 0.070 |
Why?
| | Intestine, Small | 1 | 2006 | 131 | 0.070 |
Why?
| | Rabbits | 1 | 2006 | 780 | 0.060 |
Why?
| | Biopsy | 2 | 2011 | 1079 | 0.060 |
Why?
| | Models, Animal | 1 | 2006 | 363 | 0.060 |
Why?
| | Safety | 1 | 2006 | 304 | 0.060 |
Why?
| | Postoperative Complications | 2 | 2021 | 2235 | 0.060 |
Why?
| | Hearing Disorders | 1 | 2003 | 10 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2007 | 378 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2014 | 5255 | 0.060 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 35 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2012 | 3171 | 0.060 |
Why?
| | Hospitalization | 1 | 2012 | 1785 | 0.060 |
Why?
| | Algorithms | 3 | 2017 | 1541 | 0.060 |
Why?
| | Eye Diseases | 1 | 2003 | 77 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 133 | 0.050 |
Why?
| | Hydroxyapatites | 1 | 2021 | 14 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 50 | 0.050 |
Why?
| | Esthetics | 1 | 2021 | 36 | 0.050 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.050 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.050 |
Why?
| | Facial Nerve | 1 | 2021 | 33 | 0.050 |
Why?
| | Auditory Threshold | 2 | 2011 | 36 | 0.050 |
Why?
| | Infection Control | 1 | 2022 | 135 | 0.050 |
Why?
| | Nose | 1 | 2020 | 58 | 0.050 |
Why?
| | Scala Tympani | 1 | 2020 | 8 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 4708 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 610 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2021 | 188 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 5691 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 521 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 514 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 55 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 74 | 0.040 |
Why?
| | Finland | 1 | 2019 | 71 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 188 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2018 | 27 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 184 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 749 | 0.040 |
Why?
| | Incus | 1 | 2017 | 8 | 0.040 |
Why?
| | Ear Ossicles | 1 | 2017 | 14 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 98 | 0.040 |
Why?
| | Exome | 1 | 2018 | 220 | 0.040 |
Why?
| | Stapes | 1 | 2017 | 30 | 0.040 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 49 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 409 | 0.040 |
Why?
| | Pressure | 1 | 2017 | 226 | 0.040 |
Why?
| | Forecasting | 1 | 2018 | 353 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2018 | 625 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 403 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 706 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 900 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 306 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 6 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 867 | 0.030 |
Why?
| | Time | 1 | 2014 | 77 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 1974 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2707 | 0.030 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.030 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 2 | 0.030 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 16 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.030 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 38 | 0.030 |
Why?
| | Cues | 1 | 2014 | 297 | 0.030 |
Why?
| | Microinjections | 1 | 2011 | 83 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 116 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2275 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 55 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 208 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 321 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 983 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 412 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 127 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 336 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 765 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1206 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 842 | 0.020 |
Why?
| | Probability | 1 | 2008 | 305 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 559 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4709 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 460 | 0.020 |
Why?
| | Fluorouracil | 1 | 2005 | 151 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 307 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 360 | 0.020 |
Why?
| | Cisplatin | 1 | 2005 | 271 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 814 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 556 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 965 | 0.010 |
Why?
| | United States | 1 | 2019 | 12555 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3057 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6412 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|